Angiotech Pharmaceuticals

ANP-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about ANP-T

Signal
Opinion
Expert
VAGUE
VAGUE
March 12, 2004
At the same time there stent was approved, Johnson & Johnson went partners with partners with Guidance. Long-term, this stock and their partner Boston Scientific will be very good.
Show full opinionHide full opinion
At the same time there stent was approved, Johnson & Johnson went partners with partners with Guidance. Long-term, this stock and their partner Boston Scientific will be very good.
BUY
BUY
March 4, 2004
Approval has been given for Boston Scientific to sell its drug-coated stent. A safe way to play the stent market. Also have a relationship with Guidant which expects to put a stent in the market.
Show full opinionHide full opinion
Approval has been given for Boston Scientific to sell its drug-coated stent. A safe way to play the stent market. Also have a relationship with Guidant which expects to put a stent in the market.
BUY
BUY
February 24, 2004
Down today, but things it's a short term blip. Isn't taking it out of its trend. There is a risk that their stent will not be approved but feels it is a small risk.
Show full opinionHide full opinion
Down today, but things it's a short term blip. Isn't taking it out of its trend. There is a risk that their stent will not be approved but feels it is a small risk.
BUY
BUY
February 16, 2004
Still sees some upside in the long-term. Fundamentals are good.
Show full opinionHide full opinion
Still sees some upside in the long-term. Fundamentals are good.
HOLD
HOLD
February 11, 2004
Riding the waves of Boston Scientific. Keep riding it.
Show full opinionHide full opinion
Riding the waves of Boston Scientific. Keep riding it.
BUY
BUY
February 9, 2004
Like. Nice place in market. They earn money. They're one of the best in the fierl. Positive outlook
Show full opinionHide full opinion
Like. Nice place in market. They earn money. They're one of the best in the fierl. Positive outlook
VAGUE
VAGUE
February 2, 2004
Moving average is rising. Just had a breakout. Best time to jump in is when stock hits all time high.
Show full opinionHide full opinion
Moving average is rising. Just had a breakout. Best time to jump in is when stock hits all time high.
HOLD
HOLD
January 30, 2004
Very expensive. Earnings aren't there yet. They have to sell their products. Stock market price is on potential. The potential is there, so hang on.
Show full opinionHide full opinion
Very expensive. Earnings aren't there yet. They have to sell their products. Stock market price is on potential. The potential is there, so hang on.
BUY
BUY
January 22, 2004
Have done wonderfully. A stock split is due in February. Demand for their product is very strong. Not cheap. Management has done really well.
Show full opinionHide full opinion
Have done wonderfully. A stock split is due in February. Demand for their product is very strong. Not cheap. Management has done really well.
WEAK BUY
WEAK BUY
December 23, 2003
Has a volatiltiy of earnings, trading higher than it should.
Show full opinionHide full opinion
Has a volatiltiy of earnings, trading higher than it should.
BUY
BUY
December 15, 2003
A world-class company. The drugs that cover the stents has just been approved by the FDA. A great leverage play on Boston Scientific getting a big part of the stent market.
Show full opinionHide full opinion
A world-class company. The drugs that cover the stents has just been approved by the FDA. A great leverage play on Boston Scientific getting a big part of the stent market.
DON'T BUY
DON'T BUY
December 2, 2003
A lot of its good news is priced into the stock right now.
Show full opinionHide full opinion
A lot of its good news is priced into the stock right now.
BUY
BUY
November 25, 2003
Now crossing into profitability. When their stent hits the US market, the earnings will drive a lot higher.
Show full opinionHide full opinion
Now crossing into profitability. When their stent hits the US market, the earnings will drive a lot higher.
BUY
BUY
November 6, 2003
Has moved up dramatically during the summer. Still a transforming technology. Can probably stick it in your bottom drawer and in 3/4 years time will have done very nicely.
Show full opinionHide full opinion
Has moved up dramatically during the summer. Still a transforming technology. Can probably stick it in your bottom drawer and in 3/4 years time will have done very nicely.
BUY
BUY
November 3, 2003
They have a deal with Boston Scientific to produce stents. Competition is having problems with their product, which is good news for this stock.
Show full opinionHide full opinion
They have a deal with Boston Scientific to produce stents. Competition is having problems with their product, which is good news for this stock.
Showing 91 to 105 of 140 entries